TcSR62, an RNA-binding protein, as a new potential target for anti-trypanocidal agents

Trypanosomatids are parasites of health importance that cause neglected diseases in humans and animals. Chagas’ disease, caused by Trypanosoma cruzi, affects 6–7 millions of people worldwide, mostly in Latin America, most of whom do not have access to diagnosis or treatment. Currently, there are no...

Full description

Bibliographic Details

Published in:	Frontiers in Microbiology
Main Authors:	Analía G. Níttolo, Agustina M. Chidichimo, Ana L. Benacerraf, Timothy Cardozo, M. Clara Corso, Valeria Tekiel, Javier G. De Gaudenzi, Gabriela Vanesa Levy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Subjects:	Chagas disease Trypanosoma cruzi treatment sorafenib tosylate molecular modeling resazurin
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1539778/full